Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 07-oct-2026 · last seen 07-oct-2026

Medium-Chain Triglycerides (MCT)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-29 — Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.: C. elegans study: MCT supplementation (or blocking long-chain unsaturated fatty acid synthesis) rescued α-synuclein-driven triglyceride depletion, lipid-droplet loss, and mitochondrial dysfunction; authors note a parallel observation of lower plasma TAGs in Parkinson’s cohorts (human-observational, correlational only). [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.
29-sep-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18